USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/17987
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCostru-Tașnic, Elena
dc.contributor.authorGavriliuc, Mihail
dc.contributor.authorManole, Elena
dc.date.accessioned2021-09-25T16:58:13Z
dc.date.available2021-09-25T16:58:13Z
dc.date.issued2021
dc.identifier.citationCOSTRU-TASNIC, Elena, GAVRILIUC, Mihail, MANOLE, Elena. The importance of matrix metalloproteinases in the prognosis of acute ischemic stroke patients. In: The Moldovan Medical Journal. 2021, vol. 64, no 3, pp. 44-49. ISSN 2537-6381. DOI: https://doi.org/10.52418/moldovan-med-j.64-3.21.09
dc.identifier.issn2537-6381
dc.identifier.issn2537-6373
dc.identifier.urihttps://doi.org/10.52418/moldovan-med-j.64-3.21.09
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2021/09/Moldovan-Med-J-vers-6-Sept-2021-V64-No6.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/17987
dc.description.abstractBackground: Ischemic stroke is one of the leading causes of mortality and disability worldwide. Numerous studies were performed to assess the risk of clinical deterioration of acute ischemic stroke patients, including the risk of haemorrhagic transformation. The complexity of cerebral ischemia pathology raised the possibility of a multitude of candidate-molecules to be studied as stroke biomarkers. The blood brain barrier integrity biomarkers have shown promising results both in fundamental and clinical studies. Matrix metalloproteinases have been extensively analysed and gave encouraging results for predicting unfavourable neurological outcome, including the risk for haemorrhagic transformation. Matrix metalloproteinase-9 plays a crucial role in the disruption of the blood-brain barrier following focal cerebral ischemic stroke. Elevated matrix metalloproteinase-2 levels are responsible for the degradation of tight junction proteins, basal lamina and neuronal injury after ischemia, and may contribute to infarction and hemorrhagic volume. The review provides an overview of matrix metalloproteinases’ role in the prognosis of acute ischemic stroke patients, regarding the stroke outcome and the risk of haemorrhagic transformation. Conclusions: Matrix metalloproteinases, especially gelatinases, are extensively studied for their predictive value in ischemic stroke evolution. Matrix metalloproteinase-2 and matrix metalloproteinase-9 correlate with stroke severity and haemorrhagic transformation in acute ischemic stroke, but large validation studies are needed for practical translation. Future studies should focus on developing a biomarker panel for predicting outcomes in stroke patients.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journalen_US
dc.subjectcerebrovascular accidenten_US
dc.subjectmatrix metalloproteinasesen_US
dc.subjectstroke outcomeen_US
dc.subject.ddcUDC: 616.831-005.1/.4-036.11-037:577.15en_US
dc.titleThe importance of matrix metalloproteinases in the prognosis of acute ischemic stroke patientsen_US
dc.typeArticleen_US
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 3, September 2021

Files in This Item:
File Description SizeFormat 
The_importance_of_matrix_metalloproteinases_in_the_prognosis.pdf267.47 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback